Chemotherapy-Induced Nausea and Vomiting
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Adult patients aged 20-60 years old, male and female, who meet the diagnostic criteria and are clearly diagnosed with malignant tumor stage I to III (without distant metastasis); (2) Karnofsky score>60 points (score below 60 points, many effective anti-tumor treatments cannot be achieved, therefore excluded); (3) Determine that chemotherapy will be performed and that the proposed chemotherapy plan includes drugs with moderate to high emetic effects, with or without the use of antiemetics in the treatment plan; (4) The expected survival time is 3 months or more; (5) Agree to participate in the study and be willing to provide written informed consent; (6) No other acupuncture treatment within 1 month.
Exclusion criteria
Exclusion criteria: (1) People with a history of central nervous system diseases, mental disorders, a history of psychiatric disorders, opioid addiction or dependence, extreme weakness, disability or immunodeficiency; (2) Patients with peripheral neuropathy such as peripheral neuropathy after chemotherapy that may cause TEAS to be unable to achieve effective treatment; (3)Those who are currently participating in or have participated in other clinical trials within the last 4 weeks; (4) Allergic constitution, systemic skin disease, bilateral "Neiguan" point skin incomplete can not be stimulated; (5)Failure to follow study instructions and cooperate with study procedures; (6)Concurrent radiotherapy or other anti-tumor therapy; (7)There are other health issues that may interfere with CINV symptoms, such as gastrointestinal disorders, migraines, and tinnitus
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The number of chemotherapy-Induced nausea and vomiting;The degree of chemotherapy-Induced nausea and vomiting; | — |
Secondary
| Measure | Time frame |
|---|---|
| Life quality satisfaction;Mild depressive state;Mild anxiety state; | — |
Countries
China
Contacts
The Third Affiliated Hospital of Zhejiang Chinese Medical University